Cargando…
The Real Role of β-Blockers in Daily Cardiovascular Therapy
The role of β-adrenoceptor antagonists (β-blockers) in cardiovascular therapy has been subject to diverse trends and changes over the decades. With the advent of a wide variety of excellent drugs for the treatment of antihypertension, β-blockers have been relegated from the first-line treatment of e...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591796/ https://www.ncbi.nlm.nih.gov/pubmed/28357786 http://dx.doi.org/10.1007/s40256-017-0221-8 |
_version_ | 1783262780788310016 |
---|---|
author | Dézsi, Csaba András Szentes, Veronika |
author_facet | Dézsi, Csaba András Szentes, Veronika |
author_sort | Dézsi, Csaba András |
collection | PubMed |
description | The role of β-adrenoceptor antagonists (β-blockers) in cardiovascular therapy has been subject to diverse trends and changes over the decades. With the advent of a wide variety of excellent drugs for the treatment of antihypertension, β-blockers have been relegated from the first-line treatment of essential hypertension. However, they remain the drugs of first choice in recommendations from the respective medical societies for heart failure, coronary artery disease, and atrial fibrillation as well as in hypertension complicated with heart failure, angina pectoris, or prior myocardial infarction. When indicated, cardioselective β-blockers should be prescribed in patients with diabetes mellitus or chronic obstructive pulmonary disease. We review the available evidence for the use of β-blockers in clinical conditions in which recommendations can be made for everyday practice. |
format | Online Article Text |
id | pubmed-5591796 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-55917962017-09-25 The Real Role of β-Blockers in Daily Cardiovascular Therapy Dézsi, Csaba András Szentes, Veronika Am J Cardiovasc Drugs Review Article The role of β-adrenoceptor antagonists (β-blockers) in cardiovascular therapy has been subject to diverse trends and changes over the decades. With the advent of a wide variety of excellent drugs for the treatment of antihypertension, β-blockers have been relegated from the first-line treatment of essential hypertension. However, they remain the drugs of first choice in recommendations from the respective medical societies for heart failure, coronary artery disease, and atrial fibrillation as well as in hypertension complicated with heart failure, angina pectoris, or prior myocardial infarction. When indicated, cardioselective β-blockers should be prescribed in patients with diabetes mellitus or chronic obstructive pulmonary disease. We review the available evidence for the use of β-blockers in clinical conditions in which recommendations can be made for everyday practice. Springer International Publishing 2017-03-29 2017 /pmc/articles/PMC5591796/ /pubmed/28357786 http://dx.doi.org/10.1007/s40256-017-0221-8 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Article Dézsi, Csaba András Szentes, Veronika The Real Role of β-Blockers in Daily Cardiovascular Therapy |
title | The Real Role of β-Blockers in Daily Cardiovascular Therapy |
title_full | The Real Role of β-Blockers in Daily Cardiovascular Therapy |
title_fullStr | The Real Role of β-Blockers in Daily Cardiovascular Therapy |
title_full_unstemmed | The Real Role of β-Blockers in Daily Cardiovascular Therapy |
title_short | The Real Role of β-Blockers in Daily Cardiovascular Therapy |
title_sort | real role of β-blockers in daily cardiovascular therapy |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591796/ https://www.ncbi.nlm.nih.gov/pubmed/28357786 http://dx.doi.org/10.1007/s40256-017-0221-8 |
work_keys_str_mv | AT dezsicsabaandras therealroleofbblockersindailycardiovasculartherapy AT szentesveronika therealroleofbblockersindailycardiovasculartherapy AT dezsicsabaandras realroleofbblockersindailycardiovasculartherapy AT szentesveronika realroleofbblockersindailycardiovasculartherapy |